União Europeia - português - EMA (European Medicines Agency)

mylan ireland limited - acetato de abiraterona - neoplasias prostáticas - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

União Europeia - português - EMA (European Medicines Agency)

krka, d.d., novo mesto - acetato de abiraterona - neoplasias prostáticas - terapia endócrina - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

União Europeia - português - EMA (European Medicines Agency)

accord healthcare s.l.u. - acetato de abiraterona - neoplasias prostáticas - terapia endócrina - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

sandoz do brasil indÚstria farmacÊutica ltda - acetato de abiraterona - outros antineoplasicos

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

sun farmacÊutica do brasil ltda - acetato de abiraterona - agentes antineoplÁsicos

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

teva farmacÊutica ltda. - acetato de abiraterona - outros antineoplasicos

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

dr. reddys farmacÊutica do brasil ltda - acetato de abiraterona - antineoplasico

União Europeia - português - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostática benigna neoplasias, a castração-resistente - agentes antineoplásicos - treatment of adult patients with prostate cancer.

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

sun farmacÊutica do brasil ltda - acetato de abiraterona - agentes antineoplÁsicos

Brasil - português - ANVISA (Agência Nacional de Vigilância Sanitária)

dr. reddys farmacÊutica do brasil ltda - acetato de abiraterona - antineoplasico